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Abstract High mammographic density (MD) is used as a
phenotype risk marker for developing breast cancer. During
pregnancy and lactation the breast attains full development,
with a cellular-proliferation followed by a lobular-differ-
entiation stage. This study investigates the inﬂuence of
obstetric factors on MD among pre- and post-menopausal
women. We enrolled 3,574 women aged 45–68 years who
were participating in breast cancer screening programmes
in seven screening centers. To measure MD, blind anony-
mous readings were taken by an experienced radiolo-
gist, using craniocaudal mammography and Boyd’s
semiquantitative scale. Demographic and reproductive data
were directly surveyed by purpose-trained staff at the date
of screening. The association between MD and obstetric
variables was quantiﬁed by ordinal logistic regression, with
screening centre introduced as a random effect term. We
adjusted for age, number of children and body mass index,
and stratiﬁed by menopausal status. Parity was inversely
associated with density, the probability of having high MD
decreased by 16% for each new birth (P value\0.001).
Among parous women, a positive association was detected
with duration of lactation [[9 months: odds ratio (OR) =
1.33; 95% conﬁdence interval (CI) = 1.02–1.72] and
weight of ﬁrst child ([3,500 g: OR = 1.32; 95% CI = The other members of DDM-Spain are listed in Appendix.
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DOI 10.1007/s10549-011-1936-x1.12–1.54). Age at ﬁrst birth showed a different effect in
pre- and post-menopausal women (P value for interac-
tion = 0.030). No association was found among pre-men-
opausal women. However, in post-menopausal women the
probability of having high MD increased in women who had
their ﬁrst child after the age of 30 (OR = 1.53; 95%
CI = 1.17–2.00). A higher risk associated with birth of
twins was also mainly observed in post-menopausal women
(OR = 2.02; 95% CI = 1.18–3.46). Our study shows a
greater prevalence of high MD in mothers of advanced age
at ﬁrst birth, those who had twins, those who have breastfed
for longer periods, and mothers whose ﬁrst child had an
elevated birth weight. These results suggest the inﬂuence of
hormones and growth factors over the proliferative activity
of the mammary gland.
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Introduction
Mammographic density (MD), i.e., percentage of radio-
logically dense breast tissue, is one of the strongest known
risk factors for breast cancer. This risk is four to ﬁve times
greater among women with density in more than 75% of
the breast compared to women with little or no density
[1–3].
During full-term pregnancy and lactation, the breast
attains full development due to an early growth stage fol-
lowed by a subsequent stage of lobular differentiation
marked by a change of type 1 to types 3 and 4, resulting in
protection of this organ from chemically induced carcino-
genesis [4, 5]. These endocrinological and physiological
changes are the result of complex interactions among
hormones and growth factors. These mitogens, such as
oestrogen, prolactin, and IGF-1, modify the tissue com-
position of the breast, resulting in variations in the mam-
mographic image [6, 7].
Women’s obstetric and reproductive history could thus
logically be expected to be one of the factors that could
modulate MD. Whereas previous studies have reported
positive associations between MD and older age at ﬁrst
full-term birth and nulliparity [1, 8–12], the inﬂuence of
other factors, such as duration of breastfeeding, miscar-
riages, birth of twins, and newborns’ characteristics,
remains uncertain. Some studies have reported differential
effects of reproductive variables according to menopausal
status, suggesting different susceptibility to endogenous
and exogenous factors, and to oestrogenic compounds in
particular [10, 12]. Accordingly, this study sought to
investigate the inﬂuence of reproductive factors on MD
among a group of more than 3,500 Spanish women, and to
assess whether such effects differed by menopausal status.
Materials and methods
The DDM-Spain study (Determinantes de la Densidad
Mamogra ´ﬁca en Espan ˜a—Determinants of Mammographic
Density in Spain) is a cross-sectional multicentre study
based on 3,584 women, aged 45–68 years, recruited from
speciﬁc screening centres within the Spanish Breast Cancer
Screening Programme network in the following Spanish
Autonomous Regions (Comunidades Auto ´nomas): Aragon;
Balearic Isles; Castile-Leo ´n; Catalonia; Galicia; Navarre;
and Valencia. A minimum of 500 women per screening
centre were recruited from 7 Oct 2007 to 14 July 2008.
Women previously diagnosed with breast cancer or some
other malignant disease (except non-melanoma skin can-
cers) were excluded, as were women unable to respond to
the questionnaire and those with any physical problem that
prevented a screening mammogram from being performed.
Women were contacted by telephone and invited to par-
ticipate in the study. Those who agreed to participate were
given an appointment with the interviewer at the screening
centre on the same day as that scheduled for their mam-
mogram, to answer the study questionnaire. Participation
was formalised by subjects signing an informed consent
document which, among other things, included information
on their statutory rights to data-conﬁdentiality and -pro-
tection. Participants were allocated an alphanumeric code,
consisting of a single letter denoting the particular centre,
followed by their respective number.
Each participant was required to provide access to the
craniocaudal mammogram of her left breast. To measure
MD, we used the Boyd semi-quantitative scale, which
classiﬁes density into one of six categories, namely A
(0%), B (1–10%), C (11–25%), D (26–50%), E (51–75%),
or F ([75%). Blind, anonymous readings were taken by a
single, experienced radiologist. By way of quality control,
a concordance study was undertaken on a subsample and
showed a high concordance between the ﬁrst and second
readings (weighted kappa values of 0.92) [13]. Purpose-
trained interviewers administered a structured question-
naire, which recorded demographic data, as well as data on
childhood and youth, family and personal background,
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123gynaecological, obstetric and occupational history,
domestic activities and lifestyle. Women’s height and
weight were measured twice by the interviewer in accor-
dance with standardised protocols, with a third measure-
ment being taken in cases where the ﬁrst two were
dissimilar. Average values were used to compute body
mass index (BMI). With respect to obstetric history, the
questionnaire collected information on fertility problems
and their treatment, number of miscarriages and, in the case
of women who had borne children, the number of children,
newborns’ sex and weight, year of birth, type of gestation,
and duration of maternal lactation.
MD was included as an ordinal response variable, and its
associationwithallthevariablesofinterestwasevaluatedby
using ordinal logistic models with random screening centre-
speciﬁc intercepts [14]. Ordinal logistic regression, also
known as the proportional-odds model, assumes that odds
ratios (ORs) remain constant, irrespective of the cut-off
chosen to dichotomize the ordinal classiﬁcation of MD in
twogroups:highversuslowMD.Themodelsimultaneously
estimates as many equations as the number of categories in
thedependentvariableminusone.TheBranttestwasusedto
verify this proportional odds assumption. Due to the few
women belonging to category A (4.2%) and F (5.3%) both
were combined with the adjacent group. Hence, all logistic
models included MD as an ordinal response variable with
four categories. The main exposure variables (reproductive
characteristics), as well as the remaining adjustment factors,
were deemed to be ﬁxed effects, so that their associated ORs
were constrained to be the same for women at all screening
centres. The models also included a random centre-speciﬁc
intercept term, which accounted for unexplained variations
in the baseline ORs of higher MD across screening centres,
as well as known strong determinants of MD, including age
at mammography, BMI, number of children, and meno-
pausal status.
In the next step, a global model was ﬁtted in the sub-
group of parous women, simultaneously including all
reproductive variables that were associated with MD
(number of children, age at ﬁrst full-term birth, birth of
twins, lactation, and weight of ﬁrst child) and adjusting for
age and BMI. This analysis was repeated, taking pre and
post-menopausal women separately.
All analyses were performed in Stata (StataCorp LP,
College Station, TX), using the gllamm function to ﬁt
random-intercept ordinal logistic models [15].
Results
Three thousand, ﬁve hundred and eighty-four (3,584)
women were recruited and interviewed. The average par-
ticipation rate was 74.5%, ranging from 64.7% at the
Corunna (Galicia) to 84.0% at the Zaragoza screening
centre (Aragon). MD assessment was completed for 3,567
participants. All women who developed breast cancer
within 6 months of mammography screening (n = 10)
were excluded from the analysis.
Table 1 shows the distribution of certain socio-demo-
graphic factors and reproductive variables by Boyd scale
grade, along with their ORs and 95% conﬁdence intervals
(CI), adjusted for age, BMI, menopausal status, and number
of children. There was a positive association with age at ﬁrst
birth ([29 years: OR = 1.28; 95% CI = 1.04–1.58), with a
signiﬁcant trend in evidence (P value = 0.039). An inverse
association with the number of children was also detected,
whereby the OR of having higher MD decreased by 20% for
each new birth (P value\0.001). Among women with
children, there was a greater prevalence of high MD among
those who had borne twins (OR = 1.72; 95% CI = 1.10–
2.68) and those whose ﬁrst child’s birth weight exceeded
3,500 g (OR = 1.30; 95% CI = 1.11–1.53); indeed, in the
latter case, risk rose by 4% for every 250 g increase in the
weight of the newborn (P value = 0.006). This same
association, albeit somewhat more attenuated, was likewise
observed in relation with the average weight of all the
children born of any given woman.
Finally, the risk of having higher MD was also seen to
increase with duration of maternal lactation: women who
breastfed their ﬁrst child for more than 9 months registered
a 38% increase in the odds of being in high MD categories
(OR = 1.38; 95% CI = 1.05–1.82), with a statistically
signiﬁcant trend (P value = 0.003). On examining this
result in depth, we decided to calculate each woman’s
cumulative lifetime lactation. Risk was observed to rise
until 18 months and fall off slightly thereafter among
women with the greatest cumulative lactation time. As there
was a strong correlation between duration of breastfeeding
after ﬁrst birth and cumulative duration of breastfeeding
(Spearman coefﬁcient = 0.85, P value\0.0001), only one
of these was used in subsequent analyses. Duration of breast
feeding after ﬁrst birth was chosen, as it was better reported
and did not depend on the number of children.
Table 2showsthejointanalysisofreproductivevariables
for all women who had children, stratiﬁed by menopausal
status and additionally adjusted for the above-mentioned
variables,which, in some cases(i.e.,breastfeeding duration)
were recoded, with categories having similar risks being
pooled. In general, the estimators obtained in this second
modelweresimilartothoseshowninTable 1.Theprotective
effect associated with the number of children was in evi-
dence in both pre- and post-menopausal women, though it
onlyreachedstatisticalsigniﬁcanceinthelatter([4children:
OR = 0.50; 95% CI = 0.31–0.80). Age at ﬁrst birth, how-
ever,displayeddifferenteffectsinpre-andpost-menopausal
women, with the interaction term proving statistically
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123Table 1 Characteristics of the study population by Boyd grade, and associated ORs for higher Boyd grade
N Mammographic density (%) OR
b 95% CI P value
c
0 \10 11–25 26–50 51–75 [75
Reproductive variables
Fertility problems
No 3,323 4 21 21 32 17 5 1.00
Yes with treatment 105 3 17 23 32 17 8 0.86 0.60–1.24 0.427
Yes without treatment 128 5 16 16 29 27 9 1.21 0.86–1.70 0.272
Age at ﬁrst birth
Nulliparous 318 4 11 15 35 23 12 1.27 0.95–1.72 0.111
\20 155 9 17 30 23 16 5 1.04 0.76–1.41 0.824
20–24 1,347 5 24 23 30 15 4 1.00
25–29 1,271 4 21 20 35 16 5 1.11 0.96–1.28 0.162
[29 465 4 15 17 31 27 6 1.28 1.04–1.58 0.021
Two-weekly trend 1.09 1.00–1.19 0.039
No. of children
None without miscarriages 277 4 10 16 34 24 13 1.76 1.38–2.25 \0.001
None with miscarriages 41 5 15 7 44 20 10 1.61 0.90–2.86 0.107
1 543 2 15 17 33 27 6 1.35 1.13–1.63 0.001
2 1,708 4 20 20 33 17 5 1.00
3 715 5 24 24 29 14 4 0.94 0.80–1.11 0.484
4 189 9 28 28 30 4 2 0.68 0.51–0.90 0.007
[4 83 14 39 24 19 1 2 0.47 0.31–0.72 0.001
Trend 0.80 0.76–0.85 \0.001
Birth of twins
a
No 3,169 4 21 21 32 17 5 1.00
Yes 69 3 14 19 35 22 7 1.72 1.10–2.68 0.017
Lactation ﬁrst child (months)
a
\1 Month 954 3 25 21 30 15 5 1.00
1–3 935 5 20 22 32 17 4 1.00 0.84–1.18 0.956
4–6 596 4 19 21 34 18 4 1.18 0.97–1.43 0.093
7–9 232 3 17 19 33 21 6 1.33 1.01–1.74 0.040
[9 226 5 22 20 33 17 3 1.38 1.05–1.82 0.021
Three-monthly trend 1.07 1.02–1.12 0.003
Cumulative lactation in all children
a
\1 Month 817 4 25 19 30 17 5 1.00 0.84–1.19 0.989
1–6 1,080 4 18 23 33 17 5 1.00
7–12 690 4 19 20 31 20 5 1.17 0.98–1.40 0.084
13–18 290 4 19 19 38 17 3 1.33 1.04–1.70 0.021
[18 354 7 27 22 30 10 4 1.19 0.93–1.51 0.160
Three-monthly trend 1.02 1.01–1.04 0.013
Time since weaned (years)
a
0–15 289 2 14 11 33 30 10 1.13 0.84–1.52 0.437
16–20 430 2 14 22 30 26 7 1.11 0.87–1.41 0.400
21–25 716 3 18 22 33 18 5 1.00 0.83–1.21 0.978
26–30 911 5 22 22 33 14 5 1.00
31–35 648 7 28 21 30 12 2 0.90 0.74–1.10 0.306
[35 235 6 30 26 29 8 1 0.83 0.62–1.10 0.191
Two-weekly trend 0.94 0.88–1.01 0.095
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variable was found among pre-menopausal women, in post-
menopausal women the OR rose by 18% for every 5-year
increase in age at ﬁrst birth, so that post-menopausal women
who had given birth to their ﬁrst child after the age of 30
registered a 53% excess risk of being classiﬁed in categories
of higher MD (OR = 1.53; 95% CI = 1.17–2.01). The
above-described positive association with birth of twins was
conﬁrmed mainly in post-menopausal women (OR = 1.88;
95% CI = 1.10–3.23). Although duration of maternal lac-
tationdisplayedapositiveassociationwithdensity,showing
a growing trend in pre- and post-menopausal women alike,
once again it was only in the latter that this proved to be
statistically signiﬁcant (OR = 1.07 for every 3 months of
lactation).Finally,elevatedbirthweightoftheﬁrstchildwas
associated with a greater prevalence of high MD in both
groups, though in this particular case the association was
stronger among pre-menopausal women ([3,500 g:
OR = 2.05; 95% CI = 1.41–2.98).
The analyses were repeated including still births in the
number of children, but this led to no change in the results
(data not shown).
Discussion
This article examines the association between certain
reproductive variables and MD in a sample of Spanish
women who were participating in a breast cancer screening
programme, and assesses whether the observed effects
Table 1 continued
N Mammographic density (%) OR
b 95% CI P value
c
0 \10 11–25 26–50 51–75 [75
Weight of ﬁrst child (g)
a
B3,500 778 5 22 19 31 18 5 0.94 0.79–1.11 0.440
3001–3,500 1,288 4 21 23 33 17 3 1.00
[3,500 873 4 21 21 31 18 5 1.30 1.11–1.53 0.001
Trend by 250 g 1.04 1.01–1.08 0.006
Average weight of all children
a
B3,000 707 4 21 18 31 19 6 0.98 0.83–1.16 0.800
3,001–3,500 1,388 4 19 22 33 17 4 1.00
[3,500 1,121 4 24 21 31 16 5 1.14 0.98–1.32 0.084
Trend by 250 g 1.03 1.00–1.07 0.048
Other determinants of MD
Age (years)
\50 541 1 9 13 35 31 11 1.00
50–54 979 2 17 19 33 22 7 0.87 0.69–1.10 0.229
55–59 1,002 5 20 25 32 13 4 0.76 0.59–0.99 0.039
[59 1,035 7 30 22 29 10 2 0.53 0.41– 0.70 \0.001
Two-weekly trend 0.79 0.73–0.85 \0.001
BMI
\20 66 0 9 8 23 39 21 2.45 1.44– 4.16 0.001
20–24 950 1 10 15 35 28 11 1.00
25–29 1,482 3 19 22 34 18 4 0.55 0.47–0.64 \0.001
C30 1,044 10 32 24 27 6 2 0.22 0.18–0.26 \0.001
Trend 0.55 0.50 –0.59 \0.001
Current situation with respect to menstrual period
No longer has period 2,751 5 23 23 32 14 4 1.00
Period with menstrual irregularities 381 2 14 17 31 28 8 1.38 1.10–1.72 0.006
Still has period 423 0 11 10 34 33 11 1.84 1.46–2.33 \0.001
95% CI conﬁdence interval
a Nulliparous women excluded
b ORs adjusted for age, BMI, menopausal status, and number of children. Italic ﬁgures refer to ORs and 95% CI obtained using the continuous
variable without categorization
c P value. In italic those obtained with the variable as a continuous term
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protective effect associated with parity. Among women
who have borne children, there is a greater risk of high MD
associated with the birth weight of the ﬁrst child, and this is
in evidence among pre-menopausal women in particular. In
post-menopausal women who have given birth, there is a
positive relationship between mammographic density and
age at ﬁrst birth, birth of twins and duration of lactation.
One of the main advantages of our study lies in the large
sizeandpopulation-basednature ofthe study sample.Itisthe
largestepidemiologicalstudytohaveanalysedtheassociation
between MD and breast cancer risk factors in the Spanish
population. The women recruited were attending the corre-
spondingbreastcancerscreeningcentrestowhichallSpanish
women coming within the age range deﬁned by their respec-
tive regional programmes are invited. The average participa-
tion rate was 74.5%, and ranged from 64.7% in Corunna
(Galicia) to 84.0% in Zaragoza (Aragon). Density measure-
ments were made by a single experienced radiologist and
showed a high degree of internal concordance [13]. In addi-
tion, the ordinal nature of the dependent variable was taken
into account, by using ordinal logistic regression rather than
traditional logistic regression models, which entail a loss of
valuable information by combining different MD categories.
Table 2 ORs, 95% conﬁdence intervals and P values for higher Boyd grade associated with characteristics of the study population, by
menopausal status
All women (N = 3238) Pre-menopausal women (N = 720)
e Post-menopausal women (N = 2516)
e
N OR
b 95% CI P
c N OR
b 95% CI P
c N OR
b 95% CI P
c
No. of children
d
1 543 1.29 1.05–1.58 0.015 171 1.28 0.86–1.91 0.217 372 1.30 1.02–1.65 0.032
2 1,708 1.00 408 1.00 1298 1.00
3 715 1.00 0.84–1019 0.998 113 0.88 0.57–1.34 0.537 602 1.02 0.84–1.24 0.817
4 189 0.66 0.49–0.88 0.006 28 0.56 0.25–1.28 0.169 169 0.68 0.50–0.94 0.018
[4 83 0.51 0.32–0.80 0.003 75 0.50 0.31–0.80 0.004
Trend 0.84 0.77–0.91 \0.001 0.84 0.69–1.02 0.071 0.84 0.77–0.91 \0.001
Age at ﬁrst birth
\20 155 1.00 0.72–1.37 0.979 43 1.29 0.66–2.52 0.451 112 0.90 0.62–1.30 0.581
20–24 1,347 1.00 281 1.00 1065 1.00
25–29 1,271 1.13 0.97–1.32 0.104 243 0.99 0.69–1.40 0.934 1027 1.16 0.98–1.37 0.093
[29 465 1.34 1.06–1.69 0.013 153 0.92 0.59–1.46 0.734 312 1.53 1.17–2.01 0.002
Two-weekly increase 1.12 1.02–1.22 0.020 0.94 0.78–1.12 0.471 1.18 1.06–1.32 0.002
Birth of twins
No 3,169 1.00 706 1.00 2461 1.00
Yes 69 1.74 1.08–2.83 0.024 14 1.32 0.43–4.09 0.629 55 1.88 1.10–3.23 0.021
Lactation of ﬁrst child (months)
a
\4 1,889 1.00 425 1.00 1463 1.00
4–6 596 1.13 0.95–1.34 0.175 122 1.21 0.81–1.79 0.356 474 1.12 0.92–1.36 0.259
7–9 232 1.28 0.99–1.66 0.057 98 1.28 0.82–1.98 0.276 171 1.30 0.96–1.74 0.085
[9 226 1.36 1.04–1.77 0.022 188 1.37 1.03–1.83 0.033
Three-monthly increase 1.06 1.01–1.11 0.011 1.04 0.94–1.15 0.476 1.07 1.02–1.13 0.010
Weight of ﬁrst child (g)
B3,000 778 0.92 0.78–1.09 0.346 189 1.17 0.81–1.67 0.402 588 0.86 0.71–1.04 0.124
3,001–3,500 1,288 1.00 281 1.00 1007 1.00
[3,500 873 1.31 1.11–1.53 0.001 174 2.05 1.41–2.98 \0.001 698 1.17 0.98–1.40 0.085
Increase by 250 g 1.05 1.02–1.06 0.004 1.08 1.01–1.17 0.034 1.04 1.01–1.06 0.024
95% CI conﬁdence interval
a In the group of pre-menopausal women the categories of 7–9 and[9 months were pooled due to the low number of cases
b ORs adjusted for age, BMI and the remaining variables shown in the table. Italic ﬁgures refer to ORs and 95% CI obtained using the
continuous variable without categorization
c P value. In italic P value obtained with the variable as a continuous term
d In the group of pre-menopausal women the categories of 4 and[4 children were pooled due to the low number of cases
e There were two women who failed to report their menopausal status
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cross-sectional study, which means that the effect of
changes in density patterns cannot be investigated. Second,
the explanatory variables of interest are self-reported and
so subject to the inﬂuence of possible recall bias. However,
since density assessment was blind and anonymous, any
recall bias would not be differential, thus implying an
underestimate of the effects studied. Furthermore, our
sample corresponds to the screening programme target
population (women aged 45–68 years), so that the number
of pre-menopausal women might be insufﬁcient for the
purpose of detecting signiﬁcant differences in some asso-
ciations. Finally, measurement of density was performed
by a highly experienced radiologist using a categorical
scale with a high degree of internal consistency. The use of
quantitative methods for measurement of MD is frequent in
the literature [16, 17]. Even so, such methods are not free
of subjectivity and have been validated solely for mam-
mograms taken by analogue mammography machines. In
our study, 3 of the 7 participant centres used digital images.
Parity, or having a greater number of children, has been
inversely associated with MD in many previous studies [1,
7, 8, 10–12, 18]. In our study, we detected that the OR
decreased by a mean of 16% per child. Various authors have
postulated that the reduction in MD with age and meno-
pause reﬂects the process of involution of mammary tissue
[19–21], and have even gone so far as to show an inverse
association between mammary density percentage and the
process of involution [19]. In this process, the glandular
epithelium is initially replaced by stroma and, with time, the
stroma is then replaced by fat. Completely involuted tissue
is thus made up of atrophic epithelium and fat, and would
therefore have little MD [19]. Nevertheless, the relationship
between involution and MD seems to be more complex, as
is highlighted by the fact that an inverse association
between mammary involution and parity has been described
[22]. Whereas the authors of this study suggest that the
relationship between parity and breast cancer may not be
mediated by mammary involution, other authors contend
that the state of involution may in part depend on parity
because, after successive pregnancies, stem and/or pro-
genitor cells accumulate in the mammary glands of mul-
tigestational female mice [23], a valid hypothesis for also
explaining the relationship between density and parity.
Another factor that was studied is the age at which
women have their ﬁrst child, which showed a positive
association with MD in postmenopausal women. Other
authors have also reported a positive association, though
the results are less consistent than in the case of parity [10–
12, 18, 24]. Full-term pregnancy induces a change in the
breast’s lobular structure to more differentiated lobules
[25]. This process of differentiation signiﬁcantly reduces
cell proliferation in the mammary gland [5]. Hence, the
fact of having the ﬁrst child at an early age may entail
lower sensitivity of differentiated mammary tissue to the
action of mitogens and mutagens.
With regard to breastfeeding, the combined evidence
from the Oxford Collaborative Group’s reanalysis of 47
epidemiological studies indicates that lactation is consis-
tently related to reduced breast cancer risk, decreasing by
4.3% for every 12 months of breastfeeding [26]. Never-
theless, the association between maternal lactation and MD
is not clear at present. In our study, density was observed to
increase with an increase in the duration of lactation in the
ﬁrst child, and to show a slight increase with each woman’s
cumulative lifetime lactation, taking age of ﬁrst gestation
and number of children into account in both cases. Other
authors, however, report detecting no association whatso-
ever between lactation and density [27–30], and some
studies have even described an inverse association [10, 31].
As far as we are aware, only one previous study has
examined the association between cumulative lactation and
high-density mammographic parenchymal patterns in a
rural population in northern Greece [10], and it reported an
inverse association among pre-menopausal women.
According to Russo et al. [4] the postpartum breast
retains more glandular tissue than if pregnancy and lacta-
tion had never occurred, until menopause is reached and
involution begins. This hypothesis could explain the
greater prevalence of high mammographic density detected
in the women in our study who had breastfed more
recently, as well as a greater preservation of glandular
tissue among those women who had breastfed for longer
periods. On the other hand, prolactin is a polypeptide
hormone involved in the growth and development of the
mammary gland (mammogenesis), synthesis of milk (lac-
togenesis), and maintenance of milk secretion (galacto-
poiesis) [32, 33]. As a mitogen, prolactin is also implicated
in the pathogenesis and progression of human breast cancer
[32]. Insofar as MD is concerned, previous studies have
reported a positive association between high levels of this
hormone and MD in post-menopausal women [32, 34–36].
The possible association between birth weight and the
MD of adult women has been analysed by a number of
studies. Among these, Cerhan et al. [16] detected a positive
association, mainly in post-menopausal women. This same
result was observed in a study covering 893 post-meno-
pausal Swedish women [17]. Other studies in contrast have
either detected no association [37,38] or reported an inverse
relationship[39].Tothebestofourknowledge,however,no
articletodatehasanalysedtheassociationbetweenmaternal
MD and children’s birth weight. The positive association
detected in our study might be due to variations in the
mother’s hormonal levels during pregnancy. Indeed, chil-
dren’s elevated birth weight has been associated with high
maternal levels of oestrogens and insulin-like growth factor
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which have examined the percentage of MD and circulating
levels of ovarian hormones have found no and/or an inverse
association, serum-IGF-I levels have nevertheless been
positively associated with this phenotype, fundamentally
among pre-menopausal women [9].
Hormonal factors may also be responsible for the greater
prevalence of high MD detected in women who have borne
twins in our study. This result has not been previously
reported, though higher levels of oestrogen [40, 43–47],
progesterone [45], testosterone [44], gonadotropins [40, 47–
49], alpha-fetoprotein [45], and human placental lactogen
[45, 47] have been described in mothers who have given
birth to twins. There is the possibility that some of these
womenwhohadtwinsmighthavereceivedpreviousfertility
treatment, and that the greater prevalence of high MD could
have been due to such treatments. In our study, however,
onlyfour womenwith twins had receivedpriortreatment,so
that the association between MD and the birth of identical
twins would not be attributable to this type of treatment.
Conclusions
Amongparouswomen,ourstudyshowsagreaterprevalence
of high MD in mothers of advanced age at ﬁrst birth, women
whohavebornetwins,womenwhohavebreastfedforlonger
periods, and those whose ﬁrst child had an elevated birth
weight. These results might in part be accounted for by the
inﬂuence of cumulative exposure to hormones and growth
factors, acting as breast mitogens that could modify the
composition of the stroma and mammary epithelium.
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